申请人:Uniroyal Chemical Ltd./Uniroyal Chemical Ltee
公开号:US04822813A1
公开(公告)日:1989-04-18
Novel 3-(2-haloalkyl)-1,4-oxathiins or 2-(2-haloalkyl)-1,4-dithiins, useful for regressing or inhibiting the growth of leukemia and tumors in mammals. The compounds have the formula.: ##STR1## wherein R.sub.1 is an alkyl group containing up to 4 carbon atoms, cyclohexyl or phenyl; R.sub.2 is hydrogen or ethyl; R.sub.3 and R.sub.4 are each hydrogen, methyl or ethyl, and when either R.sub.3 and R.sub.4 is methyl or ethyl, the other is hydrogen; X is halogen; and Y is oxygen or sulfur and when Y is sulfur, R.sub.3 and R.sub.4 are both hydrogen. and pharmaceutical compositions comprising said compounds in admixture with a pharmaceutically acceptable substantially non-toxic carrier.
新型3-(2-卤代烷基)-1,4-噁嗪或2-(2-卤代烷基)-1,4-二硫噁嗪,可用于逆转或抑制哺乳动物体内白血病和肿瘤的生长。这些化合物的化学式如下:##STR1## 其中R.sub.1是含有最多4个碳原子、环己烷基或苯基的烷基基团;R.sub.2是氢或乙基;R.sub.3和R.sub.4分别是氢、甲基或乙基,当R.sub.3和R.sub.4中的一个是甲基或乙基时,另一个是氢;X是卤素;Y是氧或硫,当Y是硫时,R.sub.3和R.sub.4都是氢。以及含有这些化合物与药学上可接受的基本无毒载体混合物的药物组合物。